David Walt, PhD

Senior Investigator, Brigham and Women's Hospital, Department of Pathology, Core Faculty Member-Wyss Institute, Harvard Medical School at Harvard University

David R. Walt is a member of the faculty at Harvard Medical School in the Department of Pathology at Brigham and Women’s Hospital, is a Member of the Wyss Institute at Harvard University and is a Howard Hughes Medical Institute Professor. Previously, he was University Professor at Tufts University. Dr. Walt is the Scientific Founder of Quanterix and has co-founded several other life sciences companies including Illumina Inc., Ultivue, Inc., Arbor Biotechnologies, Sherlock Biosciences and Vizgen. He also serves on the board of Exicure, Inc. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He has published over 300 papers and holds nearly 100 patents. He received a B.S. in chemistry from the University of Michigan and a Ph.D. in chemical biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.